CRISPR/Cas9-mediated SHP-1-knockout T cells combined with simvastatin enhances anti-tumor activity in humanized-PDX HCC model
CRISPR/Cas9介导的SHP-1敲除T细胞联合辛伐他汀可增强人源化PDX HCC模型中的抗肿瘤活性
期刊:iScience
影响因子:4.6
doi:10.1016/j.isci.2025.112266
Huaping Liu ,Wu Ge ,Xiaoping Yu ,Jianwei Luo ,Juan Zhang ,Min Yang ,Lu Cao ,Yangnan Zhang ,Ruike Wang ,Cejun Yang ,Pei Li ,Mengyu Tian ,XiaoPei Peng ,Lei Peng ,Di Wu ,Muqi Liu ,Qi Liang ,Shengwang Zhang ,Wei Li ,Pengfei Rong ,Hailan Li ,Xiaoqian Ma ,Wei Wang